**Core Concept**
Digitalis, a cardiac glycoside, is used to treat congestive heart failure (CHF) by enhancing the contractility of the heart muscle. This is achieved through a specific mechanism of action involving ion pumps in cardiac cells.

**Why the Correct Answer is Right**
Digitalis acts by inhibiting the Na+ K+ ATPase pump (also known as the sodium-potassium pump) in cardiac cells. Normally, this pump maintains a balance of sodium and potassium ions across the cell membrane. However, digitalis binding to the pump increases its affinity for sodium, leading to a decrease in sodium efflux from the cell. As a result, the intracellular sodium concentration increases, which in turn increases the intracellular calcium concentration. This increase in calcium triggers the release of more calcium from the sarcoplasmic reticulum, leading to increased muscle contraction and enhanced cardiac contractility. This mechanism is particularly beneficial in CHF, where the heart muscle is weakened and cannot pump blood effectively.

**Why Each Wrong Option is Incorrect**
**Option B:** Na+ K+ ATPase stimulation would actually decrease the intracellular sodium and calcium concentrations, leading to decreased cardiac contractility, which is opposite to the desired effect in CHF.
**Option C:** Blockade of calcium channels would also decrease cardiac contractility by reducing the influx of calcium ions into the cardiac cells.
**Option D:** While digitalis does affect the electrical conduction system of the heart, its primary mechanism of action in CHF is not through increasing the refractory period of the AV node, but rather through its direct effect on cardiac muscle contractility.

**Clinical Pearl / High-Yield Fact**
Digitalis toxicity can occur when the drug levels become too high, leading to increased risk of arrhythmias and cardiac arrest. This can be mitigated by closely monitoring serum digitalis levels and adjusting the dosage accordingly.

**✓ Correct Answer: A. Na+ K+ ATPase inhibition**